minocycline and Labyrinth-Diseases

minocycline has been researched along with Labyrinth-Diseases* in 2 studies

Reviews

1 review(s) available for minocycline and Labyrinth-Diseases

ArticleYear
Minocycline.
    Annals of internal medicine, 1976, Volume: 85, Issue:4

    Minocycline has proved to have a wider spectrum of activity against both aerobic and anaerobic bacteria and has enhanced tissue penetration when compared with its tetracycline congeners. The latter, and possibly the former, can be related to its increased lipophilicity in the physiologic pH range. It appears to be a superior chemoprophylactic agent against sulfonamide-resistant meningococci that do not become minocycline resistant as a result of treatment. The clinical promise of this agent has been dimmed, however, by recent reports of vestibular toxicity manifest in ambulatory patients. Though data on the frequency and severity of these symptoms are in some conflict, minocycline cannot currently be recommended for general clinical use.

    Topics: Anaerobiosis; Bacteria; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans; Labyrinth Diseases; Meningococcal Infections; Minocycline; Photosensitivity Disorders; Solubility; Staphylococcus aureus; Tetracyclines; Vestibule, Labyrinth

1976

Trials

2 trial(s) available for minocycline and Labyrinth-Diseases

ArticleYear
Minocycline.
    Annals of internal medicine, 1976, Volume: 85, Issue:4

    Minocycline has proved to have a wider spectrum of activity against both aerobic and anaerobic bacteria and has enhanced tissue penetration when compared with its tetracycline congeners. The latter, and possibly the former, can be related to its increased lipophilicity in the physiologic pH range. It appears to be a superior chemoprophylactic agent against sulfonamide-resistant meningococci that do not become minocycline resistant as a result of treatment. The clinical promise of this agent has been dimmed, however, by recent reports of vestibular toxicity manifest in ambulatory patients. Though data on the frequency and severity of these symptoms are in some conflict, minocycline cannot currently be recommended for general clinical use.

    Topics: Anaerobiosis; Bacteria; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans; Labyrinth Diseases; Meningococcal Infections; Minocycline; Photosensitivity Disorders; Solubility; Staphylococcus aureus; Tetracyclines; Vestibule, Labyrinth

1976
Minocycline: Possible vestibular side-effects.
    Lancet (London, England), 1974, Sep-28, Volume: 2, Issue:7883

    Topics: Adult; Aged; Bacteriuria; Female; Humans; Labyrinth Diseases; Male; Meningococcal Infections; Middle Aged; Minocycline; Tetracycline; Tetracyclines

1974